Addex Therapeutics ADXN
NASDAQ ADXN
$3.07 +0.09 (+3.02%)
At close: Oct 2, 2026 · 4:00 PM EDT

Addex Therapeutics (ADXN) Cash from Financing Activities (2019 - 2026)

Updated

Addex Therapeutics (ADXN) reported Cash from Financing Activities of $366,549 for Q2 2026, down 53.3% from $784,155 a year earlier but up 338.7% from the prior quarter.

Analysis

Addex Therapeutics (ADXN) Cash from Financing Activities (2019 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Addex Therapeutics' Cash from Financing Activities came in at $996,073, up 12.1% year-over-year; for FY2025, it came in at $1.48 million, down 95.9% from FY2024.

  • Cash from Financing Activities has a five-year compound annual growth rate of 95.9% (FY2020 to FY2025).
  • By year, Cash from Financing Activities came in at $36.49 million in FY2024 (+514.9%), $5.94 million in FY2023 (+84.3%), $3.22 million in FY2022 (-81.9%) and $17.79 million in FY2021.
  • Five-year quarterly Cash from Financing Activities spans a low of -$805,991 in Q1 2022 and a high of $8.85 million in Q4 2021.
  • Year over year, Cash from Financing Activities has now declined in each of the last three quarters, with an average decline of 42.8% over the last four quarters.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $83,548 (Q1 2026), $94,672 (Q4 2025) and $451,305 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 8.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -8.78 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -5.05 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 1.76 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -2.02 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -47.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -1.48 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 2.34 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -3.66 Bn
10 Addex Therapeutics 2.67 Mn 2.67 Mn - 366,548.62
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 366,548.62
Mar 31, 2026 83,548.03
Dec 31, 2025 94,672.26
Sep 30, 2025 451,304.54
Jun 30, 2025 784,155.09
Mar 31, 2025 108,990.54
Dec 31, 2024 199,035.75
Sep 30, 2024 -203,807.61
Jun 30, 2024 -63,485.82
Mar 31, 2024 188,519.73
Dec 31, 2023 -65,784.52
Sep 30, 2023 -213,932.68
Jun 30, 2023 6.26 Mn
Mar 31, 2023 -125,963.01
Dec 31, 2022 -175,321.90
Sep 30, 2022 4.33 Mn
Jun 30, 2022 -176,773.54
Mar 31, 2022 -805,990.58
Dec 31, 2021 8.85 Mn
Sep 30, 2021 -98,213.31
API Access

Addex Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ADXN&period=max&api_key=YOUR_API_KEY